CN106474365A - A kind of smokeless moxa roll treating osteoarthritis - Google Patents
A kind of smokeless moxa roll treating osteoarthritis Download PDFInfo
- Publication number
- CN106474365A CN106474365A CN201610869583.0A CN201610869583A CN106474365A CN 106474365 A CN106474365 A CN 106474365A CN 201610869583 A CN201610869583 A CN 201610869583A CN 106474365 A CN106474365 A CN 106474365A
- Authority
- CN
- China
- Prior art keywords
- parts
- carbon
- moxa roll
- chinese mugwort
- pheretima
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
- A61H39/06—Devices for heating or cooling such points within cell-life limits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
The present invention relates to a kind of smokeless moxa roll treating osteoarthritis, belong to moxa-moxibustion medicine field.Described moxa roll, is prepared by the raw materials in:150 200 parts of carbon of Chinese mugwort, 20 30 parts of Rhizoma Drynariae, 10 20 parts of Semen Nigellae, 10 20 parts of Cortex Acanthopanciss, 6 10 parts of Caulis Spatholobi, 6 10 parts of Herba Agrimoniae, 58 parts of Pheretima, 10 15 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 10 15 parts of Oryza glutinosa;Described Chinese mugwort carbon preparation method be, take be dried Folium Artemisiae Argyi boil in a covered pot over a slow fire forge into carbon, be ground into fine powder.The scientific and reasonable collocation of inventive formulation, all medicines share, treat osteoarthritis effect is significant, effective percentage reaches more than 96%.Chemical adhesive need not in addition be added in production process simultaneously, reach smokeless state, nontoxic, environmental protection during use, solve the problems, such as chemical contamination and injury.Present invention preparation is easy, using simple, with low cost, is suitable to be widely popularized.
Description
【Technical field】
The present invention relates to moxa-moxibustion medicine field, specially a kind of smokeless moxa roll treating osteoarthritis.
【Background technology】
Moxa-moxibustion is that a kind of tcm therapy using the moxa roll after burning, the outstanding moxibustion human acupoint such as moxa cone (includes outstanding moxibustion and straight
Contact), for internal medicine, surgery, gynecological, department of pediatrics, diseases of the five sense organs, subject range is quite varied, is main in ancient Chinese
The means for the treatment of disease.Moxa-moxibustion has warming YANG and invigorating QI, promoting the flow of QI in the collateral by warming the meridian, repercussive eliminating stagnation, the effect of invigorating the spleen and replenishing QI, for wet by wind and cold
And the disease effects caused by blood stasis are fairly obvious.
Moxa roll currently on the market, mostly selects Folium Artemisiae Argyi to be implant, has following defect:
(1) dense smoke producing during traditional moxa roll (post) burning, can be by respiratory tract, skin to using, accept moxibustion treatment
Doctor and patient cause allergy or other potentially injure, simultaneously strong, unpleasant long-time pollution clothes of Chinese mugwort oil coke fragrance.
(2) chemical adhesive that Modern smokeless moxa roll (post) adds when producing, is also easy to produce toxic gas harm people during burning
Body, pollution environment.
In sum, need badly a kind of cure mainly osteoarthritis drug effect more significantly single-minded, prepare simple, with low cost smokeless
Moxa roll, but have not been reported with regard to this kind of moxa roll.
【Content of the invention】
The purpose of the present invention is for deficiency of the prior art, provides one kind simply smokelessly to end using safety, preparation
Bar.
Another purpose of the present invention is to provide the purposes of above-mentioned smokeless moxa roll.
For achieving the above object, the present invention adopts the technical scheme that:
A kind of smokeless moxa roll treating osteoarthritis, is prepared by the raw materials in:Chinese mugwort carbon 150-200 part, osteomiosis
Mend 20-30 part, Semen Nigellae 10-20 part, Cortex Acanthopanciss 10-20 part, Caulis Spatholobi 6-10 part, Herba Agrimoniae 6-10 part, Pheretima 5-8 part,
Pseudobulbus Bletillae (Rhizoma Bletillae) 10-15 part, Oryza glutinosa 10-15 part;Described Chinese mugwort carbon preparation method be, take be dried Folium Artemisiae Argyi boil in a covered pot over a slow fire forge into carbon, be ground into fine powder.
Preferably, described moxa roll, is prepared by the raw materials in:150 parts of carbon of Chinese mugwort, 20 parts of Rhizoma Drynariae, Nigella damascena L.
10 parts of son, 10 parts of Cortex Acanthopanciss, 6 parts of Caulis Spatholobi, 6 parts of Herba Agrimoniae, 5 parts of Pheretima, 10 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 10 parts of Oryza glutinosa.
Preferably, described moxa roll, is prepared by the raw materials in:200 parts of carbon of Chinese mugwort, 30 parts of Rhizoma Drynariae, Nigella damascena L.
20 parts of son, 20 parts of Cortex Acanthopanciss, 10 parts of Caulis Spatholobi, 10 parts of Herba Agrimoniae, 8 parts of Pheretima, 15 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 15 parts of Oryza glutinosa.
A kind of method preparing smokeless moxa roll of the present invention, comprises the steps of:
(1) take be dried Folium Artemisiae Argyi boil in a covered pot over a slow fire forge into carbon, be ground into fine powder, obtain Chinese mugwort carbon, weigh by weight, standby;
(2) raw material Rhizoma Drynariae, Semen Nigellae, Cortex Acanthopanciss, Caulis Spatholobi, Herba Agrimoniae, Pheretima are weighed according to parts by weight;Powder
Broken, obtain Chinese medicine mixed powder, add the alcohol dipping that percent by volume is 70% to extract, filtration, reclaim ethanol, obtain filtrate, filter
Relative density 1.10-1.15 when liquid is concentrated into 70 DEG C, obtains final product Chinese medicine extract;
(3) ratio weighs Pseudobulbus Bletillae (Rhizoma Bletillae), Oryza glutinosa by weight, adds suitable quantity of water to be cooked into pasty state, with prepared Chinese medicine in step (2)
Extract mixes, and is uniformly sprayed to the Chinese mugwort carbon surface of step (1), then is placed in compressing in moxa roll mould, after taking-up nature dries in the shade
Packaging is finished product.
Further, the amount of 70% ethanol described in step (1) is 8-10 times of Chinese medicine mixed powder weight.
Further, the temperature of the Soakage extraction described in step (1) is 25 DEG C -30 DEG C, and extraction time is 3-5 days.
Purposes in the medicine of preparation treatment osteoarthritis for the moxa roll as above.
Raw material effect used by the present invention is as follows:
Chinese mugwort carbon:Dried leaves for feverfew Chinese mugwort Artemisia argyi L é vl.et Vant. form through carbonization, preserve
The fragrance of Folium Artemisiae Argyi and effect, have the effects such as promoting blood circulation to remove obstruction in the collateral, dispersing cold for relieving pain, warming the meridian for stopping bleeding for moxa-moxibustion.
Rhizoma Drynariae, is the dry rhizome of Plants of Polypodiaceae Mongolian oak Herba pteridii latiusculi Drynaria fortunei (Kunze) J.Sm..Have
Cure the wound pain relieving, effect of The strong bone of kidney tonifying.
Semen Nigellae, is cohosh Semen Nigellae Nigella glandulifera Freyn et Sint.
Dry mature seed.There is kidney-tonifying and brain tonic, the effect stimulated the menstrual flow.
Cortex Acanthopanciss, are the drying of Araliaceae acanthopanax gracilistyluses Acanthopanax gracilistylus W.W.Smith
Root bark.There is expelling wind and removing dampness, liver and kidney tonifying, bone and muscle strengthening, effect of inducing diuresis to remove edema.
Caulis Spatholobi:Rattan is dried for leguminous plant spatholobus suberectuss Spatholobus suberectus Dunn.There is promoting blood circulation
Enrich blood, menstruction regulating and pain relieving, effect of relaxing muscles and tendons and activating QI and blood in the collateral.
Pseudobulbus Bletillae (Rhizoma Bletillae):For the dry tuber of orchid Pseudobulbus Bletillae (Rhizoma Bletillae) Bletilla sfriata (Thunb.) Reiehb.f., there are receipts
Hold back the effects such as hemostasis, detumescence and promoting granulation.
Oryza glutinosa, is the rice of Oryza sativa L. var. glutinosa Matsum. OryzasativaL.var.GlutinosaMatsum shelling, has invigorating the spleen and replenishing QI, spleen invigorating
The effects such as nourishing the stomach, convergence hidroschesis.
Herba Agrimoniae, is the aerial partss of rosaceous plant Agrimony Agrimonia pilosa Ledeb..There is dredging collateral stop
Effect of pain.
Pheretima, is Ju Yin section animal Pheretima aspergillum Pheretima aspergillum (E.Perrier), popular Pheretimatschiliensis
Pheretima vulgaris Chen, power simulation Pheretima guillelmi (Michaelsen) or the blind Pheretimatschiliensis of comb
The dry body of Pheretima Pectinifera Michaelsen.There is heat clearing away arresting convulsion, effect of dredging collateral.
The invention has the beneficial effects as follows:
(1) Rhizoma Drynariae, Semen Nigellae invigorating the kidney and strengthening the bones in prescription of the present invention;Cortex Acanthopanciss liver and kidney tonifying;Caulis Spatholobi fills blood;Chinese mugwort
Carbon, Pseudobulbus Bletillae (Rhizoma Bletillae) blood circulation promoting and blood stasis dispelling;Herba Agrimoniae, Pheretima removing obstruction in the collateral to relieve pain;Oryza glutinosa invigorating middle warmer and replenishing QI.Full side play altogether invigorating the kidney and strengthening the bones, promoting blood circulation to remove obstruction in the collateral it
Work(.Kidney-reinforcing drug can support able-bodied bone, whole body QI and blood also can be made to fill, provide sufficient nutrient substance for body internal organs, organ etc., and
The a neural endocrine one immunological network orthofunction of regulation and control can balance, correct dysimmunity state.Drug for invigorating blood circulation and eliminating stasis can expand blood vessel,
Improve circulation, reduce blood stickiness, increase oxygen fortune, eliminate exudate, improve pain.The active drug composition of the present invention passes through
The mode of moxa-moxibustion enters in vivo, without the intestines and stomach, it is to avoid the intestines and stomach is upset, has no toxic side effect, process is gentle.Clinical research table
Bright, the present invention prevents and treats osteoarthritis, effect is significant.
(2) Pseudobulbus Bletillae (Rhizoma Bletillae) of the present invention and Oryza glutinosa are rich in gelatinized starch, and viscosity is strong, as the binding agent of moxa roll molding, need not be
In addition production process adds chemical adhesive, reaches smokeless state, nontoxic, environmental protection during use, solves chemistry dirt
Dye and injury problem.
(3) present invention preparation is easy, using simple, with low cost, is suitable to be widely popularized.
【Specific embodiment】
Embodiment 1
A kind of smokeless moxa roll treating osteoarthritis of the present embodiment, is prepared by the raw materials in:
150 parts of carbon of Chinese mugwort, 20 parts of Rhizoma Drynariae, 10 parts of Semen Nigellae, 10 parts of Cortex Acanthopanciss, 6 parts of Caulis Spatholobi, 6 parts of Herba Agrimoniae, Pheretima
5 parts, 10 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 10 parts of Oryza glutinosa.
The preparation method of smokeless moxa roll of the present invention, comprises the steps of:
(1) take be dried Folium Artemisiae Argyi boil in a covered pot over a slow fire forge into carbon, be ground into fine powder, obtain Chinese mugwort carbon, weigh by weight, standby;
(2) raw material Rhizoma Drynariae, Semen Nigellae, Cortex Acanthopanciss, Caulis Spatholobi, Herba Agrimoniae, Pheretima are weighed according to parts by weight;Powder
Broken, obtain Chinese medicine mixed powder, add the alcohol dipping that percent by volume is 70% to extract, the amount of wherein 70% ethanol is Chinese medicine
8-10 times of mixed powder weight, the temperature of Soakage extraction is 25 DEG C -30 DEG C, and extraction time is 3-5 days;Filtration, reclaims ethanol, obtains
Filtrate, relative density 1.10-1.15 when filtrate is concentrated into 70 DEG C, obtain final product Chinese medicine extract;
(3) ratio weighs Pseudobulbus Bletillae (Rhizoma Bletillae), Oryza glutinosa by weight, adds suitable quantity of water to be cooked into pasty state, with prepared Chinese medicine in step (2)
Extract mixes, and is uniformly sprayed to the Chinese mugwort carbon surface of step (1), then is placed in compressing in moxa roll mould, after taking-up nature dries in the shade
Packaging is finished product.
Embodiment 2
A kind of smokeless moxa roll treating osteoarthritis of the present embodiment, is prepared by the raw materials in:
Chinese mugwort 200 parts of carbon, 30 parts of Rhizoma Drynariae, 20 parts of Semen Nigellae, 20 parts of Cortex Acanthopanciss, 10 parts of Caulis Spatholobi, 10 parts of Herba Agrimoniae,
8 parts of dragon, 15 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 15 parts of Oryza glutinosa.
The smokeless moxa roll preparation method of the present embodiment is with embodiment 1.
Embodiment 3
A kind of smokeless moxa roll treating osteoarthritis of the present embodiment, is prepared by the raw materials in:
180 parts of carbon of Chinese mugwort, 25 parts of Rhizoma Drynariae, 15 parts of Semen Nigellae, 15 parts of Cortex Acanthopanciss, 8 parts of Caulis Spatholobi, 8 parts of Herba Agrimoniae, Pheretima
7 parts, 12 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 13 parts of Oryza glutinosa.
The smokeless moxa roll preparation method of the present embodiment is with embodiment 1.
The curative effect to osteoarthritis for the experimental example moxa roll of the present invention
1 case selection standard
1.1 diagnostic criteria
1.1.1 Western medicine diagnostic criteria
Clinical manifestation:1. have streptococcal infection medical history more;2. acute stage, can show multiple and migrans joint aches, multiple
Life, can be with red and swollen pain or tuberosity or erythema in large joint;3. chronic phase, can only feel joint aches.
Laboratory examination:1. resist " O " more than 1: 500;Or erythrocyte sedimentation rate speeds 2.;3. or antistreptokinase more than 80 units more than;
Or antihyaluronidase is more than 128 units 4.;Or " C " reactive protein is positive 5..
X-ray film no Bone destruction.
1.1.2 tcm diagnosis standard (cold dampness accumulation pattern):
Characteristics of incidence:How relevant with climate change.
Clinical manifestation:1. primary symptom:Joint cold type of pain is heavy;2. secondary disease:Arthroncuss, numbness weighs, joint stuffiness, and local is feared
Cold, color of the leather is not red, tactile not hot, pain increase in intensity under coldness, pain alleviated while getting warmth;3. tongue arteries and veins:The light dark tongue of enlarged tongue matter is greasy in vain or whitens, stringy and tense pulse or
String delays.Possess 1. 3. two, can determine that diagnosis in conjunction with 1-2 symptom in 2. item.
Patient 150 is collected altogether according to above-mentioned standard, is randomly divided into 3 groups, each group 50, sample no significant difference.
1.2 inclusive criteria
1. meet above-mentioned diagnostic criteria person;
2. the age is in 20-75 year person.
1.3 exclusion standard
1.3.1 do not meet above-mentioned tcm diagnosis standard person.
Though 1.3.2 meeting above-mentioned differential diagnosis in tcm standard, there is the one of following situation simultaneously:
1. the age below 20 years old, or more than 75 years old person;
2. using other drugs during observing, such as antipyretic analgesic, antirheumatic and similar medicine;
3. all do not meet inclusive criteria, not by regulation medication it is impossible to judge curative effect or data is not congruent affects the treatment and pacify
Full property judgement person.
2 Therapeutic Method
Treatment group 1-3 is respectively using the smokeless moxa roll moxibustion of embodiment 1-3.Concrete grammar is:Patient joint is entered
Row moxibustion, two once, 2 wicks, every post 10g, is within 30 days a course for the treatment of, treats 3 courses for the treatment of.
3 efficacy determinations
(1) Short Term Clinical recovery from illness symptom all disappears, and functional activity recovers normal, Primary Reference index (anti-" O ", erythrocyte sedimentation rate
Deng) result is normal;
(2) effective symptomatology eliminates or cardinal symptom eliminates, and function of joint is recovered substantially, can participate in normal work and labor
Dynamic, Primary Reference index result is normal;
(3) improvement cardinal symptom substantially eliminates, and major joint function is substantially recovered or had made marked progress, and can't take care of oneself
Switch to life can take care of oneself.Or go work or physical labor ability to switch to work and work recovered.Main physical and chemical index is
Improve;
(4) one week each side of futile treatment all no improve person.
4 results
Count each group therapeutic effect according to above-mentioned curative effect determinate standard, statistical result and total effective rate are as shown in table 1.In table
As shown by data, the total effective rate for the treatment of group is high, and work fast.It can be seen that, present invention treatment osteoarthritis can significantly improve office
Portion's blood circulation, reduces congestion, dredging the meridian, illustrates that the plurality of Chinese of the present invention merges using effect significantly, has collaborative work
With.
Table 1 each group therapeutic effect and total effective rate statistical data
Group | Recovery from illness | Effective | Take a turn for the better | Invalid | Total effective rate |
Treatment group 1 | 21 | 25 | 2 | 2 | 96.0% |
Treatment group 2 | 26 | 22 | 1 | 1 | 98.0% |
Treatment group 3 | 26 | 22 | 2 | 0 | 100.0% |
As it can be seen from table 1 embodiment 1~3 to treatment osteoarthritis effect is significant, effective percentage reach 96.0% with
On.
Described above is the detailed description for the preferable possible embodiments of the present invention, but embodiment is not limited to this
Bright patent claim, the equal change being completed under the technical spirit suggested by all present invention or modification change, all should belong to
In the covered the scope of the claims of the present invention.
Claims (7)
1. a kind of smokeless moxa roll treating osteoarthritis is it is characterised in that be prepared by the raw materials in:Chinese mugwort carbon 150-
200 parts, Rhizoma Drynariae 20-30 part, Semen Nigellae 10-20 part, Cortex Acanthopanciss 10-20 part, Caulis Spatholobi 6-10 part, Herba Agrimoniae 6-10 part,
Pheretima 5-8 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 10-15 part, Oryza glutinosa 10-15 part;Described Chinese mugwort carbon preparation method be, take be dried Folium Artemisiae Argyi boil in a covered pot over a slow fire forge into carbon, grind
Become fine powder.
2. moxa roll according to claim 1 is it is characterised in that be prepared by the raw materials in:150 parts of carbon of Chinese mugwort, bone
Broken mend 20 parts, 10 parts of Semen Nigellae, 10 parts of Cortex Acanthopanciss, 6 parts of Caulis Spatholobi, 6 parts of Herba Agrimoniae, 5 parts of Pheretima, 10 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), Oryza glutinosa 10
Part.
3. moxa roll according to claim 1 is it is characterised in that be prepared by the raw materials in:200 parts of carbon of Chinese mugwort, bone
Broken mend 30 parts, 20 parts of Semen Nigellae, 20 parts of Cortex Acanthopanciss, 10 parts of Caulis Spatholobi, 10 parts of Herba Agrimoniae, 8 parts of Pheretima, 15 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), Oryza glutinosa
15 parts.
4. a kind of method preparing moxa roll described in any one of claim 1-3 is it is characterised in that comprise the steps of:
(1) take be dried Folium Artemisiae Argyi boil in a covered pot over a slow fire forge into carbon, be ground into fine powder, obtain Chinese mugwort carbon, weigh by weight, standby;
(2) raw material Rhizoma Drynariae, Semen Nigellae, Cortex Acanthopanciss, Caulis Spatholobi, Herba Agrimoniae, Pheretima are weighed according to parts by weight;Pulverize, obtain
To Chinese medicine mixed powder, the alcohol dipping that percent by volume is 70% is added to extract, filtration, reclaim ethanol, obtain filtrate, filtrate concentrates
To relative density 1.10-1.15 when 70 DEG C, obtain final product Chinese medicine extract;
(3) ratio weighs Pseudobulbus Bletillae (Rhizoma Bletillae), Oryza glutinosa by weight, adds suitable quantity of water to be cooked into pasty state, with prepared Chinese medicine extraction in step (2)
Thing mixes, and is uniformly sprayed to the Chinese mugwort carbon surface of step (1), then is placed in compressing in moxa roll mould, takes out packaging after nature dries in the shade
It is finished product.
5. method as claimed in claim 4 it is characterised in that:The amount of 70% ethanol described in step (1) mixes for Chinese medicine
8-10 times of grain weight amount.
6. method as claimed in claim 4 it is characterised in that:The temperature of the Soakage extraction described in step (1) is 25 DEG C -30
DEG C, extraction time is 3-5 days.
7. purposes in preparation treatment osteoarthritis drugs for the moxa roll described in any one of claim 1-3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610869583.0A CN106474365A (en) | 2016-09-28 | 2016-09-28 | A kind of smokeless moxa roll treating osteoarthritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610869583.0A CN106474365A (en) | 2016-09-28 | 2016-09-28 | A kind of smokeless moxa roll treating osteoarthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106474365A true CN106474365A (en) | 2017-03-08 |
Family
ID=58268052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610869583.0A Pending CN106474365A (en) | 2016-09-28 | 2016-09-28 | A kind of smokeless moxa roll treating osteoarthritis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106474365A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107374956A (en) * | 2017-09-13 | 2017-11-24 | 刘建忠 | For producing the Chinese mugwort carbon preparation method of smokeless moxa roll |
CN108434384A (en) * | 2018-06-14 | 2018-08-24 | 山东融基健康管理股份有限公司 | A kind of Gu method stone mill moxa stick moxa and its processing technology |
CN111375032A (en) * | 2020-03-18 | 2020-07-07 | 海南医学院 | Aromatherapy moxibustion strip and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102499882A (en) * | 2011-11-22 | 2012-06-20 | 刘远安 | Gold moxa stick for treating arthralgia syndrome |
CN103860772A (en) * | 2014-03-03 | 2014-06-18 | 蒋熙 | Medicinal moxibustion for treating internal-organ meridian stasis and qi-blood disharmony diseases and preparation method of medicinal moxibustion |
CN105343293A (en) * | 2014-08-21 | 2016-02-24 | 李军 | Moxibustion medicine |
-
2016
- 2016-09-28 CN CN201610869583.0A patent/CN106474365A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102499882A (en) * | 2011-11-22 | 2012-06-20 | 刘远安 | Gold moxa stick for treating arthralgia syndrome |
CN103860772A (en) * | 2014-03-03 | 2014-06-18 | 蒋熙 | Medicinal moxibustion for treating internal-organ meridian stasis and qi-blood disharmony diseases and preparation method of medicinal moxibustion |
CN105343293A (en) * | 2014-08-21 | 2016-02-24 | 李军 | Moxibustion medicine |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107374956A (en) * | 2017-09-13 | 2017-11-24 | 刘建忠 | For producing the Chinese mugwort carbon preparation method of smokeless moxa roll |
CN107374956B (en) * | 2017-09-13 | 2019-07-19 | 刘建忠 | For producing the Chinese mugwort carbon production method of smokeless moxa roll |
CN108434384A (en) * | 2018-06-14 | 2018-08-24 | 山东融基健康管理股份有限公司 | A kind of Gu method stone mill moxa stick moxa and its processing technology |
CN111375032A (en) * | 2020-03-18 | 2020-07-07 | 海南医学院 | Aromatherapy moxibustion strip and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101804166B (en) | Traditional Chinese medicine composition for treating dermatitis and eczema of infants | |
CN103041173B (en) | Traditional Chinese medicine external preparation for curing dermatitis and eczema and preparing method thereof | |
CN101455738B (en) | Traditional Chinese medicine composition for treating eczema and preparation method thereof | |
CN104398934A (en) | Traditional Chinese medicine combination for treating cutaneous pruritus and preparation method thereof | |
CN101518600B (en) | Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof | |
CN101810835A (en) | Chinese medicinal composition for treating purpura and preparation method thereof | |
WO2014056413A1 (en) | Topical kidney and fertility reinforcing patch | |
CN104689226A (en) | Traditional Chinese medicine composition for treating children with rheumatoid arthritis and preparation method thereof | |
CN102166278A (en) | Chinese medicinal composition for treating pediatric rheumatoid arthritis and preparation method thereof | |
CN106474365A (en) | A kind of smokeless moxa roll treating osteoarthritis | |
CN102772712B (en) | Traditional Chinese medicine composition for treating heat-toxicity, flourishing and blood stasis type diabetic foot | |
CN106620392A (en) | Crab louse-removing lotion | |
CN105477129A (en) | External-use plaster for psoriasis and preparation method thereof | |
CN108619473A (en) | A kind of Chinese medicine fuming-lotion for treating diabete peripheral herve pathology | |
CN104324340A (en) | Traditional Chinese medicine preparation for treating calcaneal bone hyperplasia and preparation method of traditional Chinese medicine preparation | |
CN102805825B (en) | Drug for curing cutaneous pruritus and preparation method thereof | |
CN106474364A (en) | A kind of smokeless moxa roll treating dysmenorrhea | |
CN102671180B (en) | Medicine for treating rheumatic lumbago and preparation method thereof | |
CN105616536A (en) | Traditional Chinese medicine liniment for treating leukoderma | |
CN105079206A (en) | Pain relieving traditional Chinese medicine composition and preparation method thereof | |
CN104208317A (en) | External-use linimentum for treating hyperostosis and rheumatism cold-and-heat diseases and preparation method of external-use linimentum | |
CN103599253B (en) | Traditional Chinese medicine composition for treating winter pruritus of old people | |
CN1241580C (en) | Medicinal composition for treating hypersteogeny | |
CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
CN104436043A (en) | Analgesic anti-inflammatory ointment for treating sore and ulcer yang syndrome and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170308 |